individuals in Africa. Reducing TB burden in the era of highly active antiretroviral therapy (HAART) is a public health priority. Aim: We determined the factors associated with prevalent TB among ... patients receiving…
this study was to determine antiretroviral drug resistance patterns in patients on chronic HAART presenting with OPC. Methods: An exploratory survey was performed among HIV-infected patients on HAART ... cheilitis) and…
options A and B + (mothers on nevirapine alone, mothers on highly active antiretroviral therapy (HAART)/mothers without HAART). Results: The median age of the children was 6 months ... infection rate was 11.2% (24/214)…
risk of HIV disease progression and mortality. Few data are available to determine whether HAART ameliorates micronutrient deficiencies in HIV-positive persons. In the current study, we investigated the effects…
evaluate the clinical effi cacy, tolerability and drug resistance on highly active antiretroviral therapy (HAART), and then provide scientifi c evidence for antiretroviral therapy and reducing drug resistance Methods…
immunodefi ciency in adults and children infected with HIV to initiate and monitor HAART, but it is not widely available in resource limited countries. Objective: Th e objective ... total lymphocyte count (TLC) and CD4…
Background: The introduction of Highly Active Antiretroviral Therapy (HAART) transformed the treatment of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS), improving the quality and…
Evaluate the immunological response of HIV infected adults starting Highly Active Antiretroviral Therapy (HAART). 2. Evaluate the clinical response of highly active antiretroviral therapy in HIV infected adults. 3…
LMICs) in the magnitude of HIV related OIs in pre-highly active antiretroviral therapy (HAART) populations was reviewed, and HAART induced decline in OIs was further compared between ... LMIC, (b) the age of the…
Background: Highly active anti-retroviral therapy (HAART) has brought significant change in reducing morbidity and mortality among children living with HIV/AIDS. Decisions concerning initiation and/or shifting of…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.